Background COVID-19 is a pandemic with no specific antiviral treatments or vaccines. The
urgent needs for exploring the neutralizing antibodies from patients with different clinical …

Summary SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating
worldwide pandemic, and there is a pressing need to understand the development …

Background: Recently emerged SARS-CoV-2 variants may pose a threat to immunity
derived from prototypical SARS-CoV-2 infection or vaccination. A systematic summary of the …

Abstract The 2020 SARS-CoV-2 pandemic is caused by a zoonotic coronavirus transmitted
to humans, similar to earlier events. Whether the other, seasonally circulating coronaviruses …

Summary SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern
regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we …

Background After receiving a COVID-19 vaccine, most recipients want to know if they are
protected from infection and for how long. Since neutralizing antibodies are a correlate of …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …

COVID-19 convalescent plasma (CCP) is currently under investigation for both treatment
and post-exposure prophylaxis. The active component of CCP mediating improved outcome …

The majority of infections with SARS-CoV-2 are asymptomatic or mild without the necessity
of hospitalization. It is of importance to reveal if these patients develop an antibody response …

A correlate of protection for SARS-CoV-2 vaccines is urgently needed | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …